feed,title,long_url,short_url
Benzinga,Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics,https://benzinga.com/general/biotech/23/06/33007880/post-covid-19-how-the-covax-initiative-could-redirect-its-2-6b-surplus-to-fight-future-pandemics,https://da.gd/Kceh6
